Sigilon Therapeutics, Inc. Operating Margin 2021-2023 | SGTX
Current and historical operating margin for Sigilon Therapeutics, Inc. (SGTX) over the last 10 years. The current operating profit margin for Sigilon Therapeutics, Inc. as of June 30, 2023 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-06-30 | $0.02B | $-0.03B | -166.67% |
| 2023-03-31 | $0.02B | $-0.04B | -246.67% |
| 2022-12-31 | $0.01B | $-0.04B | -330.77% |
| 2022-09-30 | $0.01B | $-0.05B | -433.33% |
| 2022-06-30 | $0.01B | $-0.06B | -640.00% |
| 2022-03-31 | $0.01B | $-0.07B | -700.00% |
| 2021-12-31 | $0.01B | $-0.08B | -760.00% |
| 2021-09-30 | $0.01B | $-0.07B | -608.33% |
| 2021-06-30 | $0.01B | $-0.07B | -471.43% |
| 2021-03-31 | $0.01B | $-0.06B | -453.85% |
| 2020-12-31 | $0.01B | $-0.05B | -407.69% |
